Identification and validation of leucine-rich α-2-glycoprotein 1 as a noninvasive biomarker for improved precision in prostate cancer risk stratification
<p><strong>Background:</strong><br /> More accurate risk assessments are needed to improve prostate cancer management.</p><br /> <p><strong>Objective:</strong><br /> To identify blood-based protein biomarkers that provided prognostic infor...
Main Authors: | Guldvik, IJ, Zuber, V, Braadland, PR, Grytli, HH, Ramberg, H, Lilleby, W, Thiede, B, Zucknick, M, Saatcioglu, F, Gislefoss, R, Kvåle, R, George, A, Grönberg, H, Wiklund, F, Neal, DE, Gnanapragasam, VJ, Taskén, KA, Mills, IG |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
The β2-adrenergic receptor is a molecular switch for neuroendocrine transdifferentiation of prostate cancer cells
by: Braadland, PR, et al.
Published: (2019) -
Low blood levels of LRG1 before radical prostatectomy identify patients with high risk of progression to castration-resistant prostate cancer
by: Guldvik, IJ, et al.
Published: (2022) -
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
by: Ingrid Jenny Guldvik, et al.
Published: (2022-11-01) -
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
by: Berge Viktor, et al.
Published: (2011-05-01) -
Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
by: Ingrid Jenny Guldvik, et al.
Published: (2021-06-01)